muscarine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DA; Robbins, J; Selyanko, AA | 1 |
| Binmöller, FJ; Cesar, M; Reiser, G | 1 |
2 other study(ies) available for muscarine and Glioma
| Article | Year |
|---|---|
Putative M-type potassium channels in neuroblastoma-glioma hybrid cells: inhibition by muscarine and bradykinin.
Topics: Animals; Bradykinin; Cell Line, Transformed; Glioma; Hybrid Cells; Ion Channel Gating; Kinetics; Membrane Potentials; Mice; Muscarine; Muscarinic Agonists; Neuroblastoma; Potassium Channel Blockers; Potassium Channels; Rats; RNA, Messenger; Swine | 1995 |
Bradykinin and muscarine induce Ca(2+)-dependent oscillations of membrane potential in rat glioma cells indicating a rhythmic Ca2+ release from internal stores: thapsigargin and 2,5-di(tert-butyl)-1, 4-benzohydroquinone deplete InsP3-sensitive Ca2+ stores
Topics: Animals; Benzoquinones; Bradykinin; Calcium; Cytosol; Glioma; Hybrid Cells; Inositol 1,4,5-Trisphosphate; Membrane Potentials; Mice; Muscarine; Neuroblastoma; Rats; Terpenes; Thapsigargin; Tumor Cells, Cultured | 1992 |